Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 3000 Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.05 USD | +0.14% | -7.11% | +24.78% |
Mar. 14 | Monte Rosa Therapeutics Q4 Net Loss Narrows; Shares Decline | MT |
Mar. 14 | Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.78% | 353M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Monte Rosa Therapeutics, Inc. - Nasdaq
- News Monte Rosa Therapeutics, Inc.
- Monte Rosa Therapeutics, Inc.(NasdaqGS: GLUE) dropped from Russell 3000 Growth Index